Table 5.
Maternal characteristics, treatments, and outcomes among the 64 pregnant women by geographic locations
| Asia | USA | Europe | Latin America | |
|---|---|---|---|---|
| Proportion (95% CI) |
Proportion (95% CI) |
Proportion (95% CI) |
Proportion (95% CI) |
|
| Maternal Characteristics | ||||
| Age (years); mean (95% CI) | 30.00 (28.70, 31.20) | 30.90 (27.30, 34.50) | 32.8 (30.10, 35.40) | 32.2 (29.50, 34.90) |
| BMI (kg/m2); mean (95% CI) | 33.70 (5.20, 62.30) | 37.0 (30.20, 43.90) | 41.4 (32.70, 50.10) | 28.9 (25.80, 32.00) |
| Gestational age (weeks); mean (95% CI) | 36.20 (34.60, 37.80) | 28.40 (25.50, 31.30) | 33.4 (30.50, 36.30) | 29.2 (25.80, 32.50) |
| Symptomatic Presentation | 0.80 (0.59, 0.93) | 1.00 (0.77, 1.00) | 1.00 (0.75, 1.00) | 0.78 (0.40, 0.97) |
| Comorbidities | ||||
| Diabetes mellitus | 0.09 (0.00, 0.41) | 0.40 (0.12, 0.74) | 0.38 (0.14, 0.68) | 0.00 (0.00, 0.34) |
| Hypertension | 0.00 (0.00, 0.28) | 0.10 (0.00, 0.45) | 0.23 (0.05, 0.54) | 0.00 (0.00, 0.34) |
| Asthma | 0.00 (0.00, 0.28) | 0.40 (0.12, 0.74) | 0.00 (0.00, 0.25) | 0.00 (0.00, 0.34) |
| Obesity | 0.09 (0.00, 0.41) | 0.56 (0.21, 0.86) | 0.25 (0.05, 0.57) | NA |
| Treatment Profiles | ||||
| Oxygen support | 0.40 (0.21, 0.61) | 0.73 (0.45, 0.92) | 0.69 (0.39, 0.91) | 0.33 (0.07, 0.70) |
| Steroids | 0.40 (0.21, 0.61) | 0.71 (0.42, 0.92) | 0.46 (0.19, 0.75) | 0.11 (0.00, 0.48) |
| Immunosuppressants | 0.04 (0.00, 0.21) | 0.33 (0.12, 0.62) | 0.00 (0.00, 0.25) | 0.00 (0.00, 0.34) |
| Hydroxychloroquine | 0.13 (0.03, 0.32) | 0.40 (0.16, 0.68) | 0.23 (0.05, 0.54) | 0.44 (0.14, 0.79) |
| Antivirals | 0.60 (0.39, 0.79) | 0.47 (0.21, 0.73) | 0.23 (0.05, 0.54) | 0.33 (0.07, 0.70) |
| Zinc/Magnesium | 0.12 (0.03, 0.31) | 0.36 (0.13, 0.65) | 0.38 (0.14, 0.68) | 0.00 (0.00, 0.34) |
| Anticoagulants | 0.08 (0.01, 0.26) | 0.08 (0.00, 0.38) | 0.15 (0.02, 0.45) | 0.22 (0.03, 0.60) |
| Antibiotics | 0.80 (0.59, 0.93) | 0.53 (0.27, 0.79) | 0.62 (0.32, 0.86) | 0.44 (0.14, 0.79) |
| Plasma therapy/Anti-liver damage | 0.20 (0.07, 0.41) | 0.20 (0.04, 0.48) | 0.08 (0.00, 0.36) | 0.00 (0.00, 0.34) |
| Mechanical ventilation | 0.16 (0.05, 0.36) | 0.67 (0.38, 0.88) | 0.38 (0.14, 0.68) | 0.33 (0.07, 0.70) |
| Maternal & Pregnancy Outcomes | ||||
| ICU admission | 0.28 (0.12, 0.49) | 0.80 (0.52, 0.96) | 0.38 (0.14, 0.68) | 0.33 (0.07, 0.70) |
| HLOS (days) mean (95% CI) | 19.10 (13.50, 24.80) | 12.60 (9.50, 15.70) | 11.00 (5.00, 17.00) | 14.20 (2.30, 26.20) |
| Cesarean section | 0.68 (0.46, 0.85) | 0.67 (0.38, 0.88) | 0.69 (0.39, 0.91) | 0.78 (0.40, 0.97) |
| Maternal death | 0.00 (0.00, 0.14) | 0.00 (0.00, 0.22) | 0.00 (0.00, 0.25) | 0.33 (0.07, 0.70) |
| Fetal demise | 0.00 (0.00, 0.14) | 0.00 (0.00, 0.25) | 0.00 (0.00, 0.25) | 0.56 (0.21, 0.86) |
| Premature birth | 0.44 (0.24, 0.65) | 0.69 (0.41, 0.89) | 0.54 (0.25, 0.81) | 0.33 (0.07, 0.70) |
| Neonatal death | 0.04 (0.00, 0.20) | 0.00 (0.00, 0.21) | 0.00 (0.00, 0.23) | 0.00 (0.00, 0.34) |
Note: Asia includes China, India, Iran, Jordon, and Korea; Europe includes France, Italy, Netherlands, Portugal, Spain, Sweden, Turkey, and United Kingdom; South America includes Brazil and Peru
CI confidence interval, ICU intensive care unit, HLOS hospital length of stay, BMI body mass index, NA not available, USA United States of America